Hostname: page-component-8448b6f56d-42gr6 Total loading time: 0 Render date: 2024-04-19T18:36:51.715Z Has data issue: false hasContentIssue false

Verbal Communication With Providers Improves Acceptance of Antimicrobial Stewardship Interventions

Published online by Cambridge University Press:  20 May 2016

Jacob B. Morton
Affiliation:
Veterans’ Affairs Medical Center, Infectious Diseases Research Program, Providence, Rhode Island University of Rhode Island, Department of Pharmacy Practice, College of Pharmacy, Kingston, Rhode Island
Daniel J. Curzake
Affiliation:
University of Rhode Island, College of Pharmacy, Kingston, Rhode Island
Haley J. Morrill
Affiliation:
Veterans’ Affairs Medical Center, Infectious Diseases Research Program, Providence, Rhode Island University of Rhode Island, Department of Pharmacy Practice, College of Pharmacy, Kingston, Rhode Island Veterans’ Affairs Medical Center, Center of Innovation in Long-Term Support Services, Providence, RhodeIsland
Diane M. Parente
Affiliation:
Veterans’ Affairs Medical Center, Infectious Diseases Research Program, Providence, Rhode Island University of Rhode Island, Department of Pharmacy Practice, College of Pharmacy, Kingston, Rhode Island
Melissa M. Gaitanis
Affiliation:
Veterans’ Affairs Medical Center, Infectious Diseases Research Program, Providence, Rhode Island Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, Rhode Island
Kerry L. LaPlante*
Affiliation:
Veterans’ Affairs Medical Center, Infectious Diseases Research Program, Providence, Rhode Island University of Rhode Island, Department of Pharmacy Practice, College of Pharmacy, Kingston, Rhode Island Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, Rhode Island
*
Address correspondence to Kerry L. LaPlante, PharmD.,FCCP, Professor of Pharmacy, University of Rhode Island, Veterans’ Affairs Medical Center (151); Research Building 830 Chalkstone Avenue; Providence, RI 02908 (KerryLaPlante@uri.edu).
Rights & Permissions [Opens in a new window]

Abstract

Type
Letters to the Editor
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

To the Editor—Antibiotic-resistant bacteria are the greatest threat in modern medicine today. 1 The Centers for Disease Control and Prevention (CDC) estimate that more than 2 million illnesses and 23,000 deaths are attributable to antibiotic-resistant bacteria. 2 In recent years, collaborative efforts to mitigate the impact of these resistant organisms have arisen. As part of these efforts, the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) released a joint position statement emphasizing implementation of antimicrobial stewardship in all healthcare facilities. 3 Additionally, the National Action Plan for Combating Antibiotic-resistant Bacteria, stemming from President Barack Obama’s recent Executive Order, calls for a 20% reduction in inpatient antibiotic misuse by 2020 and mandates antimicrobial stewardship (AMS) in all acute-care hospitals. 4 , Reference Obama 5

While AMS is a multifaceted strategy, IDSA recommends 2 core approaches: prospective audit and feedback and formulary restriction.Reference Dellit 6 As part of prospective audit and feedback, AMS teams review patients receiving antibiotics for appropriateness of drug, duration, dose, and route. Proposed changes to antimicrobial regimens (interventions) are then relayed to the provider, often in the form of (1) a written or electronic notification placed in the patient’s chart or electronic medical record (EMR) or (2) verbal communication, including face-to-face or telephone conversations.

Although overall acceptance of AMS interventions is well documented in the literature, acceptance according to different communication methods is unknown.Reference Liew, Lee and Loh 7 Reference Pasquale, Trienski and Olexia 10 We believe this gap in the current literature to be important and worthy of exploration because less effective methods of communication for AMS may be detrimental to patient care. In an effort to optimize patient care through our AMS services, we recently retrospectively evaluated the acceptance of all verbal and EMR interventions made by the AMS team at the Providence Veterans Affairs Medical Center between March 1, 2014, and February 28, 2015. Our AMS program has been existence since September 2012.

As part of prospective audit and feedback conducted every Monday through Friday, infectious diseases (ID) pharmacy fellows reviewed all patients admitted to the medical center receiving intravenous or oral antibiotics, antifungals, or antivirals. Appropriateness of antimicrobial selection, dose, duration, route, and indication were assessed according to current evidence in ID guidelines, primary literature, as well as our facility-specific antimicrobial guidebook. Interventions were organized into 11 categories: antimicrobial discontinuation, vancomycin dosing, drug dose or duration optimization, intravenous (IV) to oral (PO) switch, de-escalation of therapy, therapeutic drug monitoring, ordering of a pertinent lab test for monitoring purposes, broadening of antimicrobial spectrum, ID consultation, change in antimicrobial regimen due to reported allergic reaction, or addressing a drug–drug interaction between an antimicrobial and another medication.

The ID pharmacy team presents patients potentially needing a change in antimicrobial regimen to a physician or lead clinical pharmacist formally trained in infectious diseases. Interventions deemed necessary by the ID physician or clinical pharmacist were then communicated to the patient’s primary provider (usually a medical resident) either by verbal communication (in person or face-to-face) or by placing a note in the patient’s electronic medical record. Notes entered into the EMR included all pertinent clinical information, the suggested intervention(s), and an evidence-based rationale for the suggested change. The provider is added as a note co-signer, alerting the provider of an intervention. The AMS team follows up on EMR notifications the following day to assess intervention acceptance status. Interventions were considered accepted if the provider implemented the intervention following EMR notification or discussion with the ID pharmacist or physician.

During the 1-year period, the AMS service reviewed 1,064 unique admissions, making 543 interventions on 384 admissions (36.1% of total admissions), with 73.1% of interventions accepted. Of these interventions, 391 (72%) were EMR notes and 152 (28%) were verbal communications. Verbal intervention acceptance was higher than EMR note acceptance (86.2% vs 68.0%; P<.0001). Subsequent subgroup analyses according to intervention type revealed only vancomycin dosing (100% vs 62.5%, P=.001), drug dose or duration optimization (88.0% vs 59.5%; P=.009), and ID consultation (100.0% vs 33.3%; P=.02) had significantly higher acceptance in the verbal arm than the nonverbal arm (Table 1).

Table 1 Frequency and Acceptance of Electronic Medical Record (EMR) and Verbal Interventions According to Intervention Type

NOTE. EMR, electronic medical record; ID, infectious diseases; IV, intravenous; PO, oral.

a Assessment of differences between verbal and EMR note acceptance.

Our results suggest the importance of verbal communication in the implementation of AMS services. For example, of the EMR note interventions not accepted, 33% were notes that were not signed and, therefore, were likely not seen by the provider. This may have been attributable to the unfamiliarity of medical residents with the EMR system, as they spend limited time within the VA, or to potential fatigue associated with the large number of notes that need to be signed by the provider.

Our results were limited in their scope due to lack of randomization according to communication method and a relatively small number of verbal interventions. Selection of communication used was largely dependent upon the ID fellow conducting AMS. However, we provide a real-world analysis that may represent many AMS program practices. As a result of our findings, verbal communication is now the primary method of providing AMS interventions at our facility, utilizing EMR notes in instances where the provider cannot be reached by pager, phone call, or face-to-face discussion. Our analysis has demonstrated the importance of effective communication as part of AMS activities. Because AMS programs have become a primary defense mechanism against antibiotic-resistant bacteria, their effectiveness is vital. By limiting the use of potentially less effective communication methods, stewardship practices may be improved, potentially reducing inappropriate antimicrobial use, improving patient outcomes, and decreasing resistance rates.

Acknowledgments

Financial support: No financial support was provided relevant to this article.

Potential conflicts of interest: Haley Morrill is supported in part by a Career Development Award from the VA New England Healthcare System and has received research funding from Merck. Kerry LaPlante has received research funding or served as an advisor or consultant for Cubist (Merck), BARD/Davol, Forest (Allergan), Cempra Pharmaceuticals, Melinta Therapeutics, The Medicines Company, and Pfizer, Inc. Jacob Morton, Daniel Curzake, Diane Parente, and Melissa Gaitanis have no financial, personal, or other relationship that could be viewed as conflicts of interest.

The views expressed are those of the authors and do not necessarily reflect the position or policy of the United States Department of Veterans Affairs. This material is based upon work supported, in part, by the Office of Research and Development, Department of Veterans Affairs.

References

1. SHEA applauds strategies outlined in National Action Plan for Combating Antibiotic-Resistant Bacteria. Society for Healthcare Epidemiology of America website. http://www.shea-online.org/View/ArticleId/348/SHEA-Applauds-Strategies-Outlined-in-National-Task-Force-for-Combating-Resistant-Bacteria-Plan.aspx. Published 2015. Accessed April 4, 2016.Google Scholar
2. Get smart: know when antibiotics work. Centers for Disease Control and Prevention website http://www.cdc.gov/getsmart/antibiotic-use/fast-facts.html. Accessed June 5, 2015.Google Scholar
3. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America. Infect Control Hosp Epidemiol 2012;33:322327.Google Scholar
4. National strategy to combat antibiotic-resistant bacteria. Centers for Disease Control and Prevention website. http://www.cdc.gov/drugresistance/national-strategy/. Accessed June 5, 2015.Google Scholar
5. Obama, B. Executive Order—Combating Antibiotic-Resistant Bacteria. The White House: Office of the Press Secretary; 2014.Google Scholar
6. Dellit, TH. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159.Google Scholar
7. Liew, YX, Lee, W, Loh, JC, et al. Impact of an antimicrobial stewardship programme on patient safety in Singapore General Hospital. Int J Antimicrob Agents 2012;40:5560.Google Scholar
8. Smith, T, Philmon, CL, Johnson, GD, et al. Antimicrobial stewardship in a community hospital: attacking the more difficult problems. Hosp Pharma 2014;49:839846.Google Scholar
9. Bartlett, JM, Siola, PL. Implementation and first-year results of an antimicrobial stewardship program at a community hospital. Am J Health-Sys Pharma 2014;71:943949.CrossRefGoogle Scholar
10. Pasquale, TR, Trienski, TL, Olexia, DE, et al. Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infections. Am J Health-Sys Pharma 2014;71:11361139.CrossRefGoogle ScholarPubMed
Figure 0

Table 1 Frequency and Acceptance of Electronic Medical Record (EMR) and Verbal Interventions According to Intervention Type